Como descrevemos no post anterior, o Diretor da Clínica Vilara, Dr. Marco Melo, esteve na Áustria para participar do Congresso Europeu de Reprodução Assistida e Embriologia e preparou um resumo dos pontos importantes abordados durante o Congresso. Já citamos alguns na postagem anterior, se você ainda não leu, clique aqui!   Conduta na baixa resposta […]

No mês de junho, entre os dias 23 e 26 de Junho foi realizado em Viena, na Áustria, o ESHRE 2019 – Congresso Europeu de Reprodução Assistida e Embriologia. Sempre em busca de novos conhecimentos, o Diretor da clínica Vilara, Dr. Marco Melo, esteve presente e preparou um resumo dos estudos e novidades na área […]

Um laboratório de Reprodução Assistida manipula gametas humanos a fim de produzir embriões humanos que tenham potencial de gerar uma gravidez. O impacto dessas atividades, tanto técnica quanto eticamente, assim como os riscos inerentes a elas, são tais que torna imprescindível o seu contínuo controle de qualidade – a fim de garantir replicabilidade e segurança […]

Authors: J Bellver, J A Martınez-Conejero, E Labarta, P Alama, Marco Melo, J Remohı, A Pellicer, J A Horcajadas (Fertility & Sterility 95: 2335–2341, 2011) OBJECTIVE: To determine whether luteal phase endometrial transcriptome is altered in obese women during the window of implantation (WOI), considering the presence of infertility, fat distribution and association with polycystic […]

Authors: Miranda SP, Traiman P, Cândido EB, Lages EL, Freitas GF, Lamaita RM, Vidigal PV, da Silva Filho AL. (Int J Gynecol Cancer- 2010; 20(9):1525-30) Abstract This study was undertaken to investigate the expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen (TAM). Postmenopausal women with endometrial polyps […]

Authors: Marco Melo, Jose Bellver, Nicolas Garrido, Marcos Meseguer, Antonio Pellicer, Jose Remohı (Fertility & Sterility 94: 958- 964, 2010) Objective: To compare the efficacy of three different gonadotropin regimens in an oocyte donation program. The analysis of cost minimization also was evaluated. Design: Prospective, randomized, controlled study. Setting: Instituto Universitario–IVI, Valencia, Spain. Patient(s): One […]

Authors: Jose Bellver, Elena Labarta, Ernesto Bosch, Marco Melo, Carmina Vidal, Jose Remoh, and Antonio Pellicer (Fertility & Sterility 94: 1065- 1071, 2010) Objective: To assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles. Design: Single-center, randomized, single-blind, placebo-controlled trial. Setting: University-affiliated infertility clinic, between February 2005 […]

Auhtors: J. Bellver, M. Meseguer, L. Muriel, S. Garcıía-Herrero, Marco Melo, A.L. Garda, J. Remohı, A. Pellicer, N. Garrido (Human Reproduction 25: 1713-1721, 2010) Background: The aim of the present study was to evaluate the implication of male factor, in terms of sperm DNA oxidation and fragmentation, and Y chromosome microdeletions in recurrent spontaneous abortion […]

Authors: Jose Bellver, Yanira Ayllon, Marcos Ferrando, Marco Melo, Eduardo Goyri, Antonio Pellicer, Jose Remohı, Marcos Meseguer. (Fertility & Sterility 2010; 93:447–454) OBJECTIVE: To compare embryo quality and reproductive outcome in our IVF program according to the women’s body mass index (BMI). DESIGN: Retrospective study. SETTING: University-affiliated infertility clinic, January 2001 and April 2007. PATIENTS: […]

Authors: Marco Melo, Cristiano E. Busso, José Bellver, Pilar Alama, Nicolas Garriso, Marcos Meseguer, Antonio Pellicer, José Remohí (Reproductive BioMedicine Online 2009; 19(4): 486-492) The use of GnRH agonists for triggering ovulation is still a controversy. Few reports are available on this issue. The primary objective was to evaluate the clinical outcome associated with GnRH […]